Logo image
In persons at intermediate risk for CVD, polypills reduce a composite of CV events at 5 y
Journal article   Peer reviewed

In persons at intermediate risk for CVD, polypills reduce a composite of CV events at 5 y

Krysta Brown and Anthony A Donato
Annals of internal medicine, v 175(1), pp JC2-JC3
Jan 2022
PMID: 34978850

Abstract

Aspirin - therapeutic use Cardiovascular Diseases - prevention & control Drug Combinations Humans Primary Prevention

Metrics

1 Record Views

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Peripheral Vascular Disease
Logo image